What if we could offer a simple and inexpensive home-based HPV cure for women worldwide?

Daré Bioscience is developing the first treatment for clearance of persistent high-risk human papillomavirus (hrHPV) infection, which causes cervical cancer. The product, called DARE-HPV, is a soft gel vaginal insert containing two antiretroviral drugs, lopinavir and ritonavir, which are well-known and already have demonstrated safety. The novel aspects of DARE-HPV are that (1) it is a minimally invasive home-use product that intervenes earlier on the path to cervical cancer; and (2) because of this early intervention, DARE-HPV aims to enable women to address their cervical health at home, eliminating the frequent “watchful waiting” visits to a health care provider that are costly, burdensome, and contribute to socioeconomic and racial disparities in cervical cancer.

Topic 1: Women's Health at Home